Compared to the tumor epicenter (n = 16.7%, 34/204), Lgr5 expression was significantly higher at the infiltrating (n = 59.5%, 110/185) and expanding fronts (n = 36.4%, 59/162) (P < 0.01) (Figure 3). The gene discussed is LGR5; the disease is neoplasm.